19 June 2013
Keywords: epo, grants, sr, pharma, core, rnai, patent
Article | 08 January 2007
SR Pharma, a leading European RNAi therapeutics company, says that the European Patent Office has granted its core RNAi patent, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 January 2007
© 2013 thepharmaletter.com